Shamana Rofaeel
Solicitor
Solicitor
Melbourne,
Australia
Shamana specialises in equity capital markets, mergers and acquisitions and other corporate transactions.
Shamana advises clients in a variety of corporate transactions and has experience in public and private mergers and acquisitions, equity capital markets and general corporate advisory work.
Experience & capabilities
Selected matters
- PYC Therapeutics Limited on its ~A$653 million capital raise
- Australian Unity on its A$160 million wholesale placement and a A$49.8 million pro rata non-renounceable entitlement offer
- HMC Capital in relation to the IPO and $2.75 billion ASX listing of DigiCo Infrastructure REIT
- Vitrafy Life Sciences on its IPO raising $35 million resulting in a market capitalisation of $117.5 million
- Chemist Warehouse on its reverse IPO and proposed backdoor listing on the ASX into Sigma with an indicative market capitalisation of A$8.8 billion
- Quadrant Private Equity on the acquisition of Birch & Waite for the reported $300-400 million
Background
Shamana holds a Bachelor of Laws (Honours) and Bachelor of Commerce (Finance) from La Trobe University. He is admitted to practise in the Supreme Court of Victoria and the High Court of Australia.
Related insights
